THIRD HEALTH POLICY
DECISION MAKERS FORUM ASIA-PACIFIC
“Public Policies and Health Industries Strategies
in the Asia-Pacific Region: Are there Win-Win Solutions?”
5 - 6 June 2015 | ESSEC Asia-Pacific, Singapore
Wu Guanzhong, Springs and Autumns in the Lotus Pond, 2003,
Oil on canvas, 50.5 x 60.5cm, Singapore Art Museum collection
One challenge for Asia-Pacific countries is to ensure the provision of pharmaceuticals and other health
technologies to their population in a sustainable manner. Beyond ensuring good quality and affordable
supply, the question lies in how to encourage companies to produce innovation adapted to their medical
needs and eventually to invest in developing additional services, production facilities and R&D on their
territories. However, global and national companies, eager to optimise their investment policies across
countries, are driven to consider favourable environment for arbitration.
This Forum will address:
Policy models considering their spill-overs and compatibility with sustainable and affordable
access to care
Experiences and concerns from global companies investing in the Asia-Pacific region
Diversity of solutions for the region, considering the variety of economies and healthcare systems
universitas
indonesia
Veritas, Probitas, Iustitia Est. 1849
Institute of Health
Economics and
Management
School of
Public Health,
Fudan University
Keio Business
School
Center for Health Economics
and Policy Studies,
Universitas Indonesia
Foreword
Dear Guests and Speakers,
A warm welcome to the Third Health Policy Decision Makers Forum Asia-Pacific!
This year, the involvement of our four academic institutions in designing the Forum is highly representative of
the aim we pursue: address issues at the interface between health policies and business, expand the scope of
our exchanges across the region, and foster shared solutions that can contribute to better meet the population
needs for appropriate access to healthcare.
Hence the theme: “Public Policies versus Health Industries Strategies in the Asia-Pacific region: Are there
Win-Win Solutions?” By health industries, we refer to pharmaceuticals, medical technologies, and information
technologies applied to healthcare. For the last two decades, we have not only observed how economic growth
and extension of universal coverage have increased the opportunities in the region for global companies; but
also how policy makers are struggling to ensure safe and affordable access of their products, and encourage
the development of research and industrial capacities in their territories.
Should the different perspectives be reconciled and if so, what are the solutions to maximise the advantage of
all stakeholders? This is the question we want to address in this Forum.
A warm thanks to Mrs. Annie Chicoye and the ESSEC team in Singapore who set up the Forum, to the companies
supporting this event, and most importantly to the speakers and chairs for devoting their time and presence
for these very insightful two days.
Yours Sincerely,
Prof. Gérard de Pouvourville
Chair, Health Systems
Director, Institute of Health Economics & Management
ESSEC Business School
Prof. Hasbullah Thabrany
Chair, Center for Health Economics &
Policy Studies, Universitas Indonesia
Prof. Hiroshi Nakamura
Professor, Keio Business School
Keio University
Prof. Wen Chen
Dean, School of Public Health
Fudan University
universitas
indonesia
Veritas, Probitas, Iustitia Est. 1849
Institute of Health
Economics and
Management
School of
Public Health,
Fudan University
Keio Business
School
Center for Health Economics
and Policy Studies,
Universitas Indonesia
Agenda — Day 1
Friday 5 June 2015 – 10:00am to 5:00pm
9:15am - 10:00am
Registration and welcome coffee
10:00am - 10:10am
Welcome to ESSEC Asia-Pacific
Prof. Cédomir Nestorovic, Director, Executive MBA Asia-Pacific, ESSEC Business School
10:10am - 10:20am
Introduction of the ESSEC Institute of Health Economics and Management and its partners
Public policies and industry strategies: What is at stake?
Prof. Gérard de Pouvourville, ESSEC Business School, France
Prof. Wen Chen, Dean of Fudan School of Public Health, China
Prof. Hiroshi Nakamura, Keio Business School, Japan
Mrs. Eka Pujiyanti, Center of Health Economics and Policy Studies, Universitas Indonesia
SESSION 1:
Health industries strategies and public policies: A variety of perspectives
Chair: Prof. Gérard de Pouvourville, ESSEC Business School, France
10:20am - 10:40am
Health reform: What is the role that industry is expected to have in contributing to achieve its goals?
Dr. Janette Loreto-Garin, Secretary of Health, Philippines
10:40am - 11:00am
How can the alignment of public policies with health industries strategy lead to better patient outcomes?
Mr. Kevin Lai, Executive Director, Bio-Medical Sciences and Consumer Businesses,
Singapore Economic Development Board (EDB)
11:00am - 11:20am
The Biosciences industry in Japan: Why and how does the Government support a strategic sector
for the country?
Prof. Hiroshi Nakamura, Keio Business School, Japan
11:20am - 11:40am
What is a favourable environment for a global company when deciding on perennial investments
in a country?
Mr. Graham Almond, Managing Director, Lumicara, Singapore
11:40am - 12:00pm
Questions & answers
12:00pm - 1:30pm
Buffet lunch at ESSEC Asia-Pacific campus (Level 5)
SESSION 2:
Are there alternative models to health industries to meet the needs of the Asia-Pacific countries?
Chair: Prof. Wen Chen, Dean of Fudan School of Public Health, China
1:30pm - 1:50pm
Healthcare industry: Finding country-specific strategies to contribute to economic growth
Prof. Gérard de Pouvourville, ESSEC Business School, France
1:50pm - 2:10pm
What are the lessons to be learnt from the Drugs for Neglected Diseases Initiative (DNDI)
Prof. Visweswaran Navaratnam, Head DNDI Regional Office, Malaysia
2:10pm - 2:30pm
Will “Digital Health” transform the business model and contribute to improved care? The US experience
Prof. Kimberley MacPherson, Berkeley University, CA, USA
2:30pm - 3:00pm
Questions & answers
3:00pm - 3:30pm
Coffee break
SESSION 3:
What are the benefits to economy and society of a strong health industry in a territory?
Chair: Prof. Hiroshi Nakamura, Keio Business School, Japan
3:30pm - 3:50pm
How can clinical research promoted by health industries contribute to the improvement of the quality
of care? The experience in China
Prof. Wang Jiyao, Director, Fudan Evidence Based Medicine Center, China
3:50pm - 4:10pm
What is the contribution of the healthcare industry to Asia-Pacific? The industry perspective
Mr. Benoît Hennion, Vice President, Asia-Pacific Speciality Care, IPSEN
4:10pm - 4:30pm
How can the development of regeneration medicine be fostered? The experience in Japan
Prof. Mime Egami, Institute of Advanced Biomedical Engineering & Sciences, Tokyo Women’s Medical
University, Japan
4:30pm - 5:00pm
Questions & answers
7:00pm - 9:30pm
Gala dinner at Shangri-La Hotel, 22 Orange Grove
Agenda — Day 2
Saturday 6 June 2015 – 8:30am to 12:30pm
8:00am - 8:30am
Breakfast
SESSION 4:
Breakout session in workshops:
Different solutions for different needs across the region:
What is at stake for the development of health industries?
8:30am - 9:45am
China - Key issues at stake for developing the efficient provision of healthcare products
Co-leaders: Prof. Ye Lu, Director of the Department of Health Economics,
Fudan School of Public Health, China
Mr. Amish Chaturvedi, Market Access Director, AbbVie Japan Asia-Pacific, Singapore
Japan - What are the triggers for developing a high technology medical devices industry?
Co-leaders: Prof. Hiroshi Nakamura, Keio Business School, Japan
Mr. Mitsunobu Sato, Vice President, Clinical Quality, Regulatory Affairs, Post Market
Surveillances Healthcare Economics, Industry Affairs Education and Training Center
Medtronic, Japan
Low middle income countries: Should an industrial policy be part of the solution for better
access to care?
Co-leaders: Dr. Kenneth Hartigan-Go, Under Secretary of Health, Philippines
Mr. Michael Swanson, Head of Public Affairs, Communication & Market Access
Asia-Pacific, Sanofi
9:45am - 10:00am
Coffee break
KEY NOTE ADDRESSES:
10:00am - 10:10am
Introduction to the Center of Health Economics and Policy Studies (CHEPS), Universitas Indonesia
Mrs. Eka Pujiyanti, CHEPS, Universitas Indonesia
10:10am - 10:30am
Are local or foreign industries part of the solution for adequate healthcare provision to the
Indonesian population? The perspective of the International Pharmaceutical Manufacturers Group
Mr. Luthfi Mardiansyah, Chairman of IMPG and President Director, Novartis, Indonesia
SESSION 5:
Public industrial policies and healthcare products policies: Should they be connected?
Chair: Mr. Joe Caputo, Regional Principal, Asia-Pacific, IMS Health
10:30am - 11:00am
Feedback from the workshops
Leaders of workshops
PANEL SESSION:
11:00am - 12:15pm
What is the eco-system for innovative an Bio-Pharma industry in China?
Mr. Joseph Cho, General Manager, R&D Based Pharmaceutical Association Committee, China
Conciliating industrial policy and regulation of expenditure: The French experience
Mr. Noël Renaudin, former Chair of the Health Products Economic Committee, France
Panelists also include:
Prof. Wen Chen, Dean of Fudan School of Public Health, China
Prof. Hiroshi Nakamura, Keio Business School, Japan
Mr. Luthfi Mardiansyah, Chairman of IMPG and President Director, Novartis, Indonesia
12:15pm - 12:30pm
Key learnings and closure of the Forum
Mr. Joe Caputo, IMS Health and Prof. Gérard de Pouvourville, ESSEC Business School, France
Chairs and Special Guests
Mr. Joe Caputo is Regional Principal, Asia-Pacific at IMS Health, the leading global information and technology
services company providing clients in the healthcare industry with comprehensive solutions to measure and
improve their performance. He is based in Singapore, leveraging 20 years of experience in the pharmaceutical
sector to help clients address the challenges of global reimbursement and market access throughout the
drug development programme. He is responsible for leading client engagements across Asia-Pacific, Japan &
Australia including real-world evidence solutions, HEOR strategy development, patient level data analysis, HTA
submissions, local market access models, opinion leader research, advisory boards and value dossier development.
Prof. Wen Chen received his Ph.D. Degree in Social Medicine and Health Management from Shanghai Medical
University in 1998 and completed research fellowship at School of Public Health, University of California at Berkeley
from August 2000 to May 2001. Currently he serves as the Dean of the School of Public Health at Fudan University.
He also served as consultant for World Health Organisation and World Bank programmes, greatly contributing to
HPSP Pilot research study in Ning Xia Hui Autonomous Region from March of 2008 till December of 2009, and World
Bank AAA project from May to August of 2004. Prof. Chen is often invited as investigator and advisor by national
and municipal governments for various research programmes in the field of Chinese healthcare system, national and
provincial health insurance, pharmacoeconomics, pharmaceutical price regulation, health financing, and etc. He had
more than 70 publications on international and Chinese health economics and management journals.
Mr. Kevin Lai presently holds the posts of Executive Director, Biomedical Sciences and Consumer Businesses at the
Singapore Economic Development Board (EDB). He joined EDB in 1999. During his time in EDB, he spent 4 years in
New York as Centre Director before returning to Singapore to head up the Medical Technology industry group. He
was again posted to London in 2009 as the Regional Director for Europe. Mr. Lai graduated from the University of
Sheffield, UK with a Bachelor’s Degree in Chemical Engineering (Hons).
Dr. Janette Petilla Loreto-Garin is the current secretary of the Department of Health of Philippines. She has 18 years
of experience in government legislation. Her legislative record reflects her advocacies for health and advancing
the welfare of women and children, having championed, among many other laws, the Reproductive Health Act,
the Cheaper Medicines Act, and the Magna Carta for Women. A cum laude graduate of B.S. Medical Techonology,
a consistent academic scholar and Dean’s list topnotcher in medical school, and a silver medalist in her Masters of
Business Administration in Health at the Ateneo de Manila University, Dr. Garin proved that working is not a hindrance
to continuous education and academic excellence. In 2011, Dr. Garin was chosen as one of the Top 100 inspiring
people in the world, delivery for women and children by Women Deliver. Secretary Janette Loreto-Garin exemplifies
hard work, wit, and compassion as her weapons in delivering sustainable universal healthcare.
Prof. Hiroshi Nakamura is a professor at Keio University, Japan. He graduated from Hitotsubashi University and
received his Ph.D. from Stanford University. In 1996, he joined Keio Business School, Keio University, as an assistant
professor. In 2005, he was promoted to professor. He serves as a faculty member of the Graduate School of Medicine
at Keio University. He is also a member of some committees in the Ministry of Health, Labour and Welfare.
Prof. Gérard de Pouvourville is Chair Professor at ESSEC Business School for Health Systems and Director of the
Institute of Health Economics and Management and is graduated from the prestigious French Ecole Polytechnique.
Prof. de Pouvourville’s major research areas are in health policy, healthcare financing and health technology assessment.
He recently co-published a book on globalisation of managerial innovations in the field of healthcare management
and is also co-author of a handbook on health economics and management. He has been an invited research scientist
at the Wharton School, University of Pennsylvania, and at the Department of Public Health, University of Montreal.
Prof. de Pouvourville is an advisor to the French Ministry of Health, to the French National Sickness Fund and consults
for major pharmaceutical companies.
Mr. Noel Renaudin graduated from the prestigious National School of Administration, where French senior public
executives are prepared for public careers. He was initially appointed at the Prime Minister services before joining
the Ministry of Economy and Finance. He audited health and social security public accounts and chaired between
1999 and 2011, the Economic Committee for Healthcare Products. Mr. Renaudin was in charge of regulating the
pharmaceutical and medical expenditure by the statutory health insurance, with due consideration of the public
industrial policy of this important sector in the French Economy.
Prof. Hasbullah Thabrany, Prof, MD, DrPH is currently the Chair of the Center for Health Economics and Policy Studies
at Universitas Indonesia, Jakarta. His area of expertise is in health policy and healthcare financing. He has been one of
the key advisors in healthcare and social security reform in Indonesia. He was a member of the President Task Force
in Social Security Reform leading to current establishment of the National Health Insurance in Indonesia.
ESSEC Business School
Established in 1907 in Paris, France, ESSEC Business School is an academic institution of excellence which has been characterised
by its pioneering spirit throughout its history. A research-driven institution committed to the development of alliances with leading
universities, ESSEC strives to expose its students and participants to cutting-edge knowledge. The school offers a comprehensive
range of programmes (Ph.D., EMBA and executive programmes, MBAs, Specialised Masters, Master of Science in Management,
Bachelor in Business Administration) focused on developing the creativity and multicultural mind-set of each individual. Strategically
headquartered in Singapore since 2005, ESSEC Asia-Pacific aims to conduct influential high-level research in Asia. The school also
delivers academic and executive programmes with Asian insights and global perspectives by leveraging on a worldclass multicultural
faculty body and a regional network of high level academic and corporate partnerships.
Institute of Health Economics and Management, ESSEC Business School
ESSEC Business School has dedicated over 20 years catering to the needs of higher education for top healthcare executives. The
Institute of Health Economics and Management, ESSEC Business School hosts two eminent chairs - Chair of Health Systems and Chair
of Therapeutic Innovation. Together with a team of committed faculty members and permanent researchers, the institute offers a
wide variety of executive education programmes for middle and senior managers working in health organisations such as hospitals,
biopharmaceutical companies and public health agencies.
School of Public Health, Fudan University
School of Public Health, Fudan University (FUSPH) is one of the top schools of public health in China, providing research intensive
programmes dedicated to training highly qualified professionals for preventive medicine and health care management, conducting
scientific research and academic services, and providing evidence-based policy recommendations for disease prevention and control
and health system at local and national level. FUSPH focuses on promoting health at the population level, controlling major diseases
and informing policy decision making.
Keio Business School
Keio Business School develops leaders who can envision and materialise original business concepts. Here, scholars and students
of diverse backgrounds find enjoyment in learning together, delivering world-class research, and integrating academic theory with
business experience.
Center for Health Economics and Policy Studies, Universitas Indonesia
The Center for Health Economics and Policy Studies (CHEPS), known in Indonesia as “Pusat Kajian Ekonomi dan Kebijakan Kesehatan
(PKEKK)” is a research center within the School of Public Health of Universitas Indonesia. It consists of researchers with academic
and practical experience in health economics, health insurance, health financing, health administration and related policy in Indonesia.
The Institute benefits from educational grants from ABBVIE, DEERFIELD MANAGEMENT, IPSEN, JOHNSON&JOHNSON, MEDTRONIC,
SANOFI, SHIRE, UCB and VIFOR PHARMA. It is fully dedicated to funding the development of activities of the Institute in Asia-Pacific,
including the intensive HTA programmes and the Health Policy Forums.
The Forum also benefits from additional grants from
Institute of Health Economics and Management (Contact Information)
France
Mrs. Annie Chicoye
Executive Director for Development
chicoye@essec.fr | annie.chicoye@gmail.com
For more information, please visit www.essec.edu/asia
Singapore
Dr. Allen Lai
Director, IHEM Asia-Pacific
allen.lai@essec.edu
ESSEC | CPE Registration number 200511927D | Period of registration: 30 June 2011 - 29 June 2017
The Institute of Health Economics and Management Sponsorship: